Hikma Pharmaceuticals PLC (CHIX:HIKl) Stock News, Headlines & Updates
Hikma Pharmaceuticals PLC Stock News from GuruFocus
- 1
Jul 02, 2025
Hikma Pharmaceuticals PLC (HKMPY) Secures FDA Approval for TYZAVANâ„¢ Vancomycin Injection | HKMPY stock news
GuruFocus News • 8:10am
Hikma receives FDA approval for TYZAVANâ„¢ (Vancomycin Injection, USP) in the US
PRNewswire • 8:00am
Hikma receives FDA approval for TYZAVANâ„¢ (Vancomycin Injection, USP) in the US | HKMPY Stock News
GuruFocus News • 7:17am
Jun 30, 2025
Hikma Pharmaceuticals (HKMPF) Commits $1 Billion to U.S. Expansion
GuruFocus News • 1:55am
Jun 28, 2025
Hikma Pharmaceuticals PLC (HKMPY) Announces $1 Billion Investment to Expand US Manufacturing and R&D | HKMPY stock news
GuruFocus News • 11:01am
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines
PRNewswire • 11:00am
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines | HKMPY Stock News
GuruFocus News • 10:15am
May 27, 2025
FDA Approves Hikma Pharmaceuticals' STARJEMZA® as a Biosimilar to Stelara® | HKMPY stock news
GuruFocus News • 2:01am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news